Sotera Health Company Northern District of Ohio February 7, 2023 Class Period: 11/20/2020 – 9/19/2022Lead Plaintiff Deadline: March 27, 2023 Join Investigation Principle Contacts Pamela MayerPMayer@kaplanfox.com NEW YORK, NY – February 7, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Sotera Health Company (“Sotera” or the “Company”) (NASDAQ: SHC). A complaint has been filed on behalf of investors who purchased or otherwise acquired Sotera common stock pursuant and/or traceable to the Company’s November 20, 2020 initial public offering or March 18, 2021 secondary offering, or purchased or otherwise acquired Sotera common stock between November 20, 2020 and September 19, 2022 (the “Class Period”). Click here to join investigation. If you acquired Sotera common stock and would like to discuss this case or our investigation, please contact us by emailing pmayer@kaplanfox.com or by calling (646) 315-9003 or our toll free number 1 (800) 290-1952. If you are a member of the proposed Class, you may move the court no later than March 27, 2023 to serve as a lead plaintiff for the purported class. If you have losses, we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery. According to the complaint, on September 19, 2022, in a lawsuit arising from Sotera’s emissions of the hazardous gas Ethylene Oxide (“EtO”), an Illinois state court jury found Sotera liable for the plaintiff’s cancer. Specifically, the jury awarded the plaintiff $363 million in damages, including $38 million in compensatory damages and $325 million in punitive damages. Further, according to the complaint, the jury cited “willful and wanton” misconduct by Sotera and its Sterigenics business in not preventing toxic EtO emissions and in failing to warn about the severe health hazard posed by the Company’s Illinois facility. Following this news, Sotera’s stock price fell $4.90 per share, or 33.3%, to close at $9.83 per share on September 19, 2022. WHY CONTACT KAPLAN FOX – Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this Notice, your rights, or your interests, please contact: Pamela Mayer KAPLAN FOX & KILSHEIMER LLP850 Third Avenue, 14th FloorNew York, NewYork 10022(646) 315-9003E-mail: pmayer@kaplanfox.com Laurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704Fax: (415) 772-4707E-mail: lking@kaplanfox.com Connect with Kaplan Fox. Receive a complimentary case review now. Contact Us PowerSchool Holdings, Inc. See the Case Jabil, Inc. See the Case Zoetis, Inc. See the Case Globe Life Inc. See the Case Uniswap Labs See the Case Luna Innovations Incorporated See the Case Perion Network Ltd. See the Case Autodesk, Inc. See the Case Shoals Technologies Group, Inc. See the Case Vuzix Corporation See the Case bluebird bio, Inc. See the Case Sonder Holdings Inc. See the Case
